Inflammatory bowel disease and guillain barre syndrome in FCHO1 deficiency
| dc.authorid | 0000-0002-4551-5433 | |
| dc.authorid | 0000-0002-9710-8653 | |
| dc.contributor.author | Aydemir, Sezin | |
| dc.contributor.author | İşlek, Ali | |
| dc.contributor.author | Nepesov, Serdar | |
| dc.contributor.author | Yaman, Yöntem | |
| dc.contributor.author | Baysoy, Gökhan | |
| dc.contributor.author | Beşer, Ömer Faruk | |
| dc.contributor.author | Çullu Çokuğraş, Fügen | |
| dc.contributor.author | Barış, Safa | |
| dc.contributor.author | Karakoç Aydıner, Elif | |
| dc.contributor.author | Çokuğraş, Haluk | |
| dc.contributor.author | Hubrack, Satanay Z. | |
| dc.contributor.author | Kendir Demirkol, Yasemin | |
| dc.contributor.author | Lo, Bernice | |
| dc.contributor.author | Kıykım, Ayça | |
| dc.contributor.author | Özen, Ahmet | |
| dc.date.accessioned | 2021-10-14T09:48:48Z | |
| dc.date.available | 2021-10-14T09:48:48Z | |
| dc.date.issued | 2021 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı | |
| dc.description.abstract | To the Editor: FCH And Mu Domain Containing Endocytic Adaptor 1 (FCHO1) gene encodes a protein that plays a critical role in clathrin-mediated endocytosis, a biological process that maintains cellular functions in signaling, nutrient- and growth factor- uptake, and diferentiation [1–3]. Recently, biallelic mutations in FCHO1 were linked to a combined immunodefciency that is characterized by recurrent infections caused by bacteria, viruses, mycobacteria, fungi, T cell lymphopenia, and hypogammaglobulinemia [4, 5]. | |
| dc.description.sponsorship | Sidra Precision Medicine Program | en_US |
| dc.identifier.citation | Aydemir, S., İşlek, A., Nepesov, S., Yaman, Y., Baysoy, G., Beşer, Ö. F. ... Özen, A. (2021). Inflammatory bowel disease and guillain barre syndrome in FCHO1 deficiency. Journal of Clinical Immunology, 41(6), 1406-1410. https://dx.doi.org/10.1007/s10875-021-01042-2 | |
| dc.identifier.doi | 10.1007/s10875-021-01042-2 | |
| dc.identifier.endpage | 1410 | |
| dc.identifier.issn | 0271-9142 | |
| dc.identifier.issn | 1573-2592 | |
| dc.identifier.issue | 6 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 1406 | |
| dc.identifier.uri | https://dx.doi.org/10.1007/s10875-021-01042-2 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/8450 | |
| dc.identifier.volume | 41 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Springer | |
| dc.relation.ispartof | Journal of Clinical Immunology | en_US |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | FCHO1 Deficiency | |
| dc.subject | Guillain Barre Syndrome | |
| dc.subject | Bowel Disease | |
| dc.title | Inflammatory bowel disease and guillain barre syndrome in FCHO1 deficiency | |
| dc.type | Editorial |











